Table 1 Results of gene burden testing for different gene masks of UQCRC1

From: Protein-truncating variants in UQCRC1 are associated with Parkinson’s disease: evidence from half-million people

Mask

Carrier

Case

BOLT-LMM

Logistic Regression

SKAT

Beta

SE

P

OR

P

PSKAT

PSKAT-O

High confidence PTVa

120

6

0.041

0.009

1.20E−06

6.59(2.84–15.27)

1.12E-05

1.17E−06

4.34E−08

Missense variants with CADD > 0.25

990

6

0.003

0.009

3.20E−01

0.67(0.30–1.49)

3.21E-01

9.44E−01

5.13E−01

Missense variants with AlphaMissense > 0.9

123

2

0.007

0.008

4.20E−01

1.82(0.45–7.43)

4.04E-01

4.26E−01

5.92E−01

Missense variants with REVEL > 0.7

36

0

Missense variants with AlphaMissense > 0.7

241

3

0.003

0.006

6.20E−01

1.35(0.43–4.25)

6.04E−01

5.08E−01

7.34E−01

Missense variants with AlphaMissense > 0.56

285

3

0.001

0.006

8.40E−01

1.15(0.37–3.60)

8.12E−01

7.29E−01

9.14E−01

Missense variants with REVEL > 0.5

342

3

0.0004

0.005

9.20E−01

0.95(0.30–2.97)

9.31E−01

6.13E−01

8.30E−01

Sensitivity Analyses

High confidence PTVa

118

6

0.042

0.009

7.50E−07

6.79(2.92–15.77)

8.37E−06

9.86E−07

1.42E−08

Missense variants with CADD > 0.25

976

6

0.003

0.008

3.40E−01

0.68(0.30–1.51)

3.42E−01

9.43E−01

5.42E−01

Missense variants with AlphaMissense > 0.9

122

2

0.007

0.008

4.00E−01

1.88(0.46–7.68)

3.79E−01

4.00E−01

5.59E−01

Missense variants with REVEL > 0.7

36

0

 

Missense variants with AlphaMissense > 0.7

240

3

0.003

0.006

6.00E−01

1.38(0.44–4.33)

5.82E−01

4.85E−01

7.10E−01

Missense variants with AlphaMissense > 0.56

283

3

0.001

0.006

8.20E−01

1.17(0.37–3.66)

7.89E−01

7.06E−01

9.00E−01

Missense variants with REVEL > 0.5

340

3

0.0005

0.005

9.30E−01

0.96(0.31–3.00)

9.43E−01

6.11E−01

8.29E−01

  1. aPTVs: stop-gained, splice acceptor, and splice donor variants.